Announcements Trials

Browse Landscape

Phase

Status

Unknown 1 Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1 Other hematologic neoplasm 1

Conditions

Neoplasm Metastasis 1

Interventions

Standard of Care 4 Radiotherapy 4 Oxaliplatin 4 tislelizumab 3 anlotinib 2 Radiation 2 Paclitaxel 2 Capecitabine 2 130-nm albumin-bound paclitaxel 2 vedolizumab 1 trastuzumab deruxtecan 1 trametinib 1 toripalimab 1 surufatinib 1 pembrolizumab 1 ivosidenib 1 disitamab vedotin 1 coenzyme Q10 1 cemiplimab 1 blinatumomab 1 Whole Genome Sequencing 1 Ursodeoxycholic Acid 1 Ultrasonography 1 Tretinoin 1 Thymopentin 1 Surgical Procedures, Operative 1 Sequence Analysis, RNA 1 Respiratory Rate 1 Radiotherapy, Intensity-Modulated 1 Radiosurgery 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Arsenic Trioxide × Tumor-Agnostic × Clear all

NCT07348107 2026-01-16

ATARI-PDAC

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase 1 Not yet recruiting

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡